Epi 299: Journal Club Including Discussion of Persistent Opioid Use After Ophthalmic Surgery, Racial Disparities in Clinical Trial Recruitment, and Telehealth COVID-19 Experience Straight From The Cutter's Mouth: A Retina Podcast
-
- Education
Drs. Avni Finn, Priya Vakharia, and M. Ali Khan join for a journal club discussion of three recent articles from major ophthalmology journals:
Persistent Opioid Use After Ophthalmic Surgery (https://www.aaojournal.org/article/S0161-6420(21)00315-8/abstract)
Racial Disparities in Clinical Trials (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2778782)
Telehealth During COVID-19 (https://www.ajo.com/article/S0002-9394(21)00213-0/fulltext)
Relevant Financial Disclosures: Dr. Sridhar has consulted for Regeneron, Genentech, Alcon, Dorc, and Oxurion. Dr. Finn has consulted for Genentech and Allergan. Dr. Yonekawa has consulted for Alcon, Alimera, Allergan, and Genentech. Dr. Vakharia has consulted for Genentech.
Drs. Avni Finn, Priya Vakharia, and M. Ali Khan join for a journal club discussion of three recent articles from major ophthalmology journals:
Persistent Opioid Use After Ophthalmic Surgery (https://www.aaojournal.org/article/S0161-6420(21)00315-8/abstract)
Racial Disparities in Clinical Trials (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2778782)
Telehealth During COVID-19 (https://www.ajo.com/article/S0002-9394(21)00213-0/fulltext)
Relevant Financial Disclosures: Dr. Sridhar has consulted for Regeneron, Genentech, Alcon, Dorc, and Oxurion. Dr. Finn has consulted for Genentech and Allergan. Dr. Yonekawa has consulted for Alcon, Alimera, Allergan, and Genentech. Dr. Vakharia has consulted for Genentech.